Jiangsu Hengrui Medicine
600276.SS
#389
Rank
โ‚น5.281 T
Marketcap
โ‚น795.71
Share price
1.36%
Change (1 day)
38.82%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2025 (TTM): โ‚น10.51

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is โ‚น11.53. In 2024 the company made an earnings per share (EPS) of โ‚น12.34 an increase over its 2023 EPS that were of โ‚น8.66.

EPS history for Jiangsu Hengrui Medicine from 2000 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น10.51-14.86%
2024โ‚น12.3442.43%
2023โ‚น8.668.77%
2022โ‚น7.97-20.62%
2021โ‚น10.03-26.59%
2020โ‚น13.6727.24%
2019โ‚น10.7428.41%
2018โ‚น8.3720.04%
2017โ‚น6.9731.21%
2016โ‚น5.3111.46%
2015โ‚น4.7736.27%
2014โ‚น3.5019.77%
2013โ‚น2.9218.05%
2012โ‚น2.4723.9%
2011โ‚น2.0026.9%
2010โ‚น1.5712.37%
2009โ‚น1.4056.6%
2008โ‚น0.899.18%
2007โ‚น0.82114.48%
2006โ‚น0.3864.83%
2005โ‚น0.2335.55%
2004โ‚น0.1729.73%
2003โ‚น0.1319.86%
2002โ‚น0.11-2.71%
2001โ‚น0.111.02%
2000โ‚น0.11